Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mertens

Showing results (71-80 of 211) with videos related to

Pageof 22
Sort By:
International Journal of Molecular Sciences|August 26, 2023
BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular TargetsFrancesco Claps, Nicola Pavan, Luca Ongaro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary CancersMarinus J Hagens, Pim J van Leeuwen, Maurits Wondergem, et al.
European Urology Oncology|September 1, 2024
Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG)Roberto Contieri, Mark S Soloway, Paolo Gontero, et al.
Journal of Clinical Medicine|August 10, 2024
The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current LiteratureFrancesco Claps, Arianna Biasatti, Luca Di Gianfrancesco, et al.
Acta Dermato-Venereologica|March 18, 2016
Drug Survival and Predictors of Drug Survival for Methotrexate Treatment in a Retrospective Cohort of Adult Patients with Localized SclerodermaJorre S Mertens, Juul M van den Reek, Wietske Kievit, et al.
BJU International|September 24, 2013
Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy aloneLaura S Mertens, Richard P Meijer, Wim Meinhardt, et al.
Urology|November 20, 2013
Induction chemotherapy followed by surgery in node positive bladder cancerRichard P Meijer, Laura S Mertens, Bas W van Rhijn, et al.
Acta Dermato-Venereologica|November 20, 2015
Use of Mycophenolate Mofetil in Patients with Severe Localized Scleroderma Resistant or Intolerant to MethotrexateJorre S Mertens, Diane Marsman, Peter C M van de Kerkhof, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2019
Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic SclerosisTiago Carvalheiro, Alsya J Affandi, Beatriz Malvar-Fernández, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Prospective Evaluation of FDG-PET/CT for On-treatment Assessment of Response to Neoadjuvant or Induction Chemotherapy in Invasive Bladder CancerSarah M H Einerhand, Charlotte S Voskuilen, Elies E Fransen van de Putte, et al.
Pageof 22

Showing results (71-80 of 211) with videos related to

Sort By:
Pageof 22
International Journal of Molecular Sciences|August 26, 2023
BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer: Current Treatment Landscape and Novel Emerging Molecular TargetsFrancesco Claps, Nicola Pavan, Luca Ongaro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2024
A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary CancersMarinus J Hagens, Pim J van Leeuwen, Maurits Wondergem, et al.
European Urology Oncology|September 1, 2024
Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG)Roberto Contieri, Mark S Soloway, Paolo Gontero, et al.
Journal of Clinical Medicine|August 10, 2024
The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current LiteratureFrancesco Claps, Arianna Biasatti, Luca Di Gianfrancesco, et al.
Acta Dermato-Venereologica|March 18, 2016
Drug Survival and Predictors of Drug Survival for Methotrexate Treatment in a Retrospective Cohort of Adult Patients with Localized SclerodermaJorre S Mertens, Juul M van den Reek, Wietske Kievit, et al.
BJU International|September 24, 2013
Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy aloneLaura S Mertens, Richard P Meijer, Wim Meinhardt, et al.
Urology|November 20, 2013
Induction chemotherapy followed by surgery in node positive bladder cancerRichard P Meijer, Laura S Mertens, Bas W van Rhijn, et al.
Acta Dermato-Venereologica|November 20, 2015
Use of Mycophenolate Mofetil in Patients with Severe Localized Scleroderma Resistant or Intolerant to MethotrexateJorre S Mertens, Diane Marsman, Peter C M van de Kerkhof, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2019
Induction of Inflammation and Fibrosis by Semaphorin 4A in Systemic SclerosisTiago Carvalheiro, Alsya J Affandi, Beatriz Malvar-Fernández, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Prospective Evaluation of FDG-PET/CT for On-treatment Assessment of Response to Neoadjuvant or Induction Chemotherapy in Invasive Bladder CancerSarah M H Einerhand, Charlotte S Voskuilen, Elies E Fransen van de Putte, et al.
Pageof 22